European Medicines Agency Updates Product Information and Safety Recommendations

The European Medicines Agency (EMA) has released updated product information wording and new recommendations from its Pharmacovigilance Risk Assessment Committee (PRAC). These updates, adopted during a June 2026 meeting, reflect ongoing efforts to monitor medicine safety. The changes are part of routine pharmacovigilance activities to ensure drug information is current and accurate.